Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Sanara MedTech (SMTI) over the last 11 years, with Q3 2025 value amounting to $1.1 million.

  • Sanara MedTech's Capital Expenditures rose 1154779.02% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 235576.69%. This contributed to the annual value of $205848.0 for FY2024, which is 2239.36% down from last year.
  • Sanara MedTech's Capital Expenditures amounted to $1.1 million in Q3 2025, which was up 1154779.02% from $1.8 million recorded in Q2 2025.
  • Sanara MedTech's 5-year Capital Expenditures high stood at $1.8 million for Q2 2025, and its period low was $4391.0 during Q1 2021.
  • Its 5-year average for Capital Expenditures is $280708.8, with a median of $53364.0 in 2022.
  • In the last 5 years, Sanara MedTech's Capital Expenditures crashed by 9465.95% in 2024 and then skyrocketed by 1154779.02% in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's Capital Expenditures stood at $141710.0 in 2021, then tumbled by 62.34% to $53364.0 in 2022, then rose by 1.71% to $54276.0 in 2023, then surged by 32.97% to $72172.0 in 2024, then soared by 1368.0% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.8 million for Q2 2025, and $1.7 million during Q1 2025.